Showing 1–20 of 21 results
Age-related Macular Degeneration Blood
Fresh Age-related Macular Degeneration Blood – IRB-consented blood samples collected from donors diagnosed with age-related macular degeneration (AMD). Ideal for ophthalmological, immunology, and inflammation-based research.
Age-related Macular Degeneration Leukopak
LeukoCore™ Age-related Macular Degeneration Leukopak products contain concentrated immune cells from donors with clinically confirmed Age-related Macular Degeneration (AMD), collected via apheresis. Ideal for high-yield studies on AMD-related inflammation, cytokine signaling, and immune cell profiling.
Age-related Macular Degeneration PBMC
Age-related Macular Degeneration PBMC samples are collected from clinically confirmed Age-related Macular Degeneration donors and cryopreserved for downstream immunology and ophthalmological research. Ideal for studying inflammatory pathways, immune cell responses, and therapeutic development in Age-related Macular Degeneration.
Age-related Macular Degeneration Plasma
Age-related Macular Degeneration Plasma – Cryopreserved human plasma collected from clinically confirmed age-related macular degeneration (AMD) donors. Age-related Macular Degeneration plasma is ideal for inflammation studies, cytokine profiling, and ophthalmologically-focused biomarker research.
Age-related Macular Degeneration Serum
Age-related Macular Degeneration Serum – Human serum samples collected from clinically confirmed age-related macular degeneration (AMD) donors. Ideal for ophthalmological, cytokine profiling, and inflammation-related research.
Dravet Syndrome PBMC
Dravet Syndrome PBMC samples are isolated from donors with genetically and clinically confirmed Dravet syndrome. Ideal for studying neuroinflammation, SCN1A-related immune dysregulation, and the immune system’s role in seizure disorders.
Dravet Syndrome Plasma
Dravet Syndrome Plasma samples are collected from donors diagnosed with Dravet syndrome. Suitable for analyzing inflammatory cytokines, seizure-related metabolic changes, and potential biomarkers of disease severity and treatment response.
Dravet Syndrome Serum
Dravet Syndrome Serum samples are derived from donors with confirmed Dravet syndrome. Useful for assessing antiepileptic drug levels, inflammatory mediators, and systemic responses associated with epilepsy and neurodevelopmental delay.
Dravet Syndrome Whole Blood
Dravet Syndrome Whole Blood samples are obtained from donors with clinically diagnosed Dravet syndrome. Valuable for transcriptomic analysis, immune cell profiling, and exploring gene expression patterns associated with SCN1A mutations and epileptic encephalopathy.
Retinitis Pigmentosa PBMC
Retinitis Pigmentosa PBMC samples are isolated from donors with genetically confirmed Retinitis Pigmentosa (RP). Ideal for studying immune involvement in retinal degeneration, systemic inflammation, and the role of gene mutations affecting photoreceptor survival in RP.
Retinitis Pigmentosa Plasma
Retinitis Pigmentosa Plasma samples are collected from donors diagnosed with Retinitis Pigmentosa (RP). Suitable for analyzing circulating inflammatory markers, oxidative stress indicators, and potential biomarkers linked to disease progression in RP.
Retinitis Pigmentosa Serum
Retinitis Pigmentosa Serum samples are derived from donors with confirmed Retinitis Pigmentosa (RP). Useful for evaluating antioxidant levels, immune mediators, and systemic biomarkers associated with photoreceptor loss and retinal dysfunction in RP.
Retinitis Pigmentosa Whole Blood
Retinitis Pigmentosa Whole Blood samples are obtained from donors with clinically or genetically diagnosed Retinitis Pigmentosa (RP). Valuable for genomic and transcriptomic studies, particularly for identifying RP-associated mutations and pathways involved in retinal degeneration.
Stargardt Disease PBMC
Stargardt Disease PBMC samples are isolated from donors with genetically confirmed Stargardt Disease (STGD). Ideal for investigating immune cell involvement, inflammation, and retinal degeneration pathways in STGD.
Stargardt Disease Plasma
Stargardt Disease Plasma samples are collected from donors diagnosed with Stargardt Disease (STGD). Suitable for analyzing circulating inflammatory markers, oxidative stress indicators, and lipid metabolism profiles associated with retinal degeneration in STGD.
Stargardt Disease Serum
Stargardt Disease Human Serum samples are derived from donors with confirmed Stargardt Disease (STGD). Useful for evaluating systemic biomarkers, including vitamin A derivatives and lipofuscin-related compounds linked to STGD progression.
Stargardt Disease Whole Blood
Stargardt Disease Whole Blood samples are obtained from donors with clinically or genetically diagnosed Stargardt Disease (STGD). Valuable for genomic and transcriptomic studies to identify ABCA4 mutations and molecular pathways involved in STGD pathogenesis.
Thyroid Eye Disease PBMC
Thyroid Eye Disease PBMC samples are isolated from donors with clinically confirmed Thyroid Eye Disease (TED). Ideal for studying autoimmune responses, T cell and B cell activation, and fibroblast-immune interactions driving orbital inflammation and tissue remodeling in TED.
Thyroid Eye Disease Plasma
Thyroid Eye Disease Plasma samples are collected from donors diagnosed with Thyroid Eye Disease (TED). Suitable for analyzing circulating cytokines, thyroid-stimulating immunoglobulins (TSI), and biomarkers of inflammation, fibrosis, and disease activity in TED.
Thyroid Eye Disease Serum
Thyroid Eye Disease Serum samples are derived from donors with confirmed Thyroid Eye Disease (TED). Useful for measuring TSI, anti-TSH receptor antibodies, and systemic markers linked to thyroid autoimmunity and TED severity.